These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38494656)

  • 1. A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035.
    Bauermeister J; Lin W; Tingler R; Liu A; Chariyalertsak S; Hoesley C; Gonzales P; Ho K; Kayange N; Phillips TP; Johnson S; Brown E; Zemanek J; Jacobson CE; Doncel GF; Piper J;
    J Int AIDS Soc; 2024 Mar; 27(3):e26219. PubMed ID: 38494656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products.
    Giguere R; Balán IC; Kutner BA; Choi SK; Tingler R; Johnson S; Macagna N; Webster J; Liu A; Chariyalertsak S; Hoesley C; Gonzales P; Ho K; Kayange N; Palanee-Phillips T; Brown E; Zemanek J; Jacobson CE; Doncel GF; Piper J; Bauermeister JA;
    AIDS Behav; 2024 Aug; 28(8):2577-2589. PubMed ID: 38740628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035).
    Bauermeister JA; Dominguez Islas C; Jiao Y; Tingler R; Brown E; Zemanek J; Giguere R; Balan I; Johnson S; Macagna N; Lucas J; Rose M; Jacobson C; Collins C; Livant E; Singh D; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper J;
    PLoS One; 2023; 18(4):e0284339. PubMed ID: 37043527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial).
    Choi SK; Bauermeister J; Tingler RC; Johnson S; Macagna N; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper JM;
    BMC Public Health; 2023 Dec; 23(1):2464. PubMed ID: 38066471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men.
    Biello KB; Valente PK; da Silva DT; Lin W; Drab R; Hightow-Weidman L; Mayer KH; Bauermeister JA;
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26096. PubMed ID: 37439061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru.
    Peinado J; Lama JR; Galea JT; Segura P; Casapia M; Ortiz A; Montano SM; Kochel T; Sánchez J
    J Int Assoc Provid AIDS Care; 2013; 12(4):278-83. PubMed ID: 23422742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
    Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM
    Lancet Infect Dis; 2014 Jun; 14(6):468-75. PubMed ID: 24613084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
    Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
    J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand.
    Newman PA; Roungprakhon S; Tepjan S
    J Int AIDS Soc; 2013 Aug; 16(1):18476. PubMed ID: 23911116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stated preferences for new HIV prevention technologies among men who have sex with men in India: A discrete choice experiment.
    Cameron MP; Newman PA; Chakrapani V; Shunmugam M; Roungprakhon S; Rawat S; Baruah D; Nelson R; Tepjan S; Scarpa R
    PLoS One; 2024; 19(7):e0289396. PubMed ID: 39046999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
    Carballo-Diéguez A; Balán IC; Brown W; Giguere R; Dolezal C; Leu CS; Marzinke MA; Hendrix CW; Piper JM; Richardson BA; Grossman C; Johnson S; Gomez K; Horn S; Kunjara Na Ayudhya RP; Patterson K; Jacobson C; Bekker LG; Chariyalertsak S; Chitwarakorn A; Gonzales P; Holtz TH; Liu A; Mayer KH; Zorrilla C; Lama J; McGowan I; Cranston RD
    PLoS One; 2017; 12(7):e0181607. PubMed ID: 28750059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Anal Sex Roles Associated with Preferences for Pre-Exposure Prophylaxis Administration Modalities Among Men Who Have Sex with Men?
    Goedel WC; Schneider JA; Hambrick HR; Kreski NT; Morganstein JG; Park SH; Mgbako O; Duncan DT
    Arch Sex Behav; 2018 Oct; 47(7):2123-2133. PubMed ID: 29192368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and Physicians.
    Tagliaferri Rael C; Giguere R; Bryndza Tfaily E; Sutton S; Horn E; Schieffer RJ; Hendrix C; D'Aquila RT; Hope TJ
    AIDS Res Hum Retroviruses; 2024 Oct; 40(10):591-605. PubMed ID: 38753738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men.
    Tang EC; Galea JT; Kinsler JJ; Gonzales P; Sobieszczyk ME; Sanchez J; Lama JR
    Sex Transm Infect; 2016 May; 92(3):200-5. PubMed ID: 26574569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.